{"transactions":[{"id":768282,"issuer":{"id":789,"kind":"organization","name":"Newsmax Inc.","symbol":"NMAX"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2026-05-21T20:57:21.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":23940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2025 Omnibus Equity Incentive Plan and a Stock Option Grant Notice and Option Agreement. The option shall become exercisable on the 12-month anniversary of the grant date, provided that the Reporting Person continues to provide services to the Issuer through such date."}],"balance_after":23940,"derivative":{"exercise_price":7.31,"exercise_date":"2027-05-20","expiration_date":"0036-05-20","underlying":"Class B Common Stock","underlying_shares":23940},"source":{"system":"sec-edgar","filing":"0001628280-26-037364","document":"wk-form4_1779397037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026478/000162828026037364/wk-form4_1779397037.xml","form_type":"4"}},{"id":779467,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-14T20:58:43.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy, and was not sold to the Reporting Person. As such, the Reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest on the earlier of the one-year anniversary of the date of grant and the date of Issuer's next Annual Meeting following the date of grant, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":10958,"derivative":{"exercise_price":24.63,"expiration_date":"2036-05-11","underlying":"Common Stock","underlying_shares":10958},"source":{"system":"sec-edgar","filing":"0002008212-26-000004","document":"wk-form4_1778792320.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000200821226000004/wk-form4_1778792320.xml","form_type":"4"}},{"id":947231,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:47:14.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":7189,"price":11.82,"value":84973.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $85,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1,797 shares underlying the option shall vest on March 31, 2026, 1,797 shares underlying the option shall vest on June 30, 2026, 1,798 shares underlying the option shall vest on September 30, 2026 and 1,797 shares underlying the option shall vest on December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":7189,"derivative":{"exercise_price":16.59,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":7189},"source":{"system":"sec-edgar","filing":"0002008212-26-000002","document":"wk-form4_1767736023.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000200821226000002/wk-form4_1767736023.xml","form_type":"4"}},{"id":1147715,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-15T20:16:40.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":15287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest on the earlier of the one-year anniversary of the date of grant and the date of Issuer's next Annual Meeting following the date of grant, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15287,"derivative":{"exercise_price":2.37,"expiration_date":"2035-05-12","underlying":"Common Stock","underlying_shares":15287},"source":{"system":"sec-edgar","filing":"0001999480-25-000040","document":"wk-form4_1747340192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000199948025000040/wk-form4_1747340192.xml","form_type":"4"}},{"id":1177806,"issuer":{"id":789,"kind":"organization","name":"Newsmax Inc.","symbol":"NMAX"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2025-04-04T10:18:57.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2025 Omnibus Equity Incentive Plan and a Stock Option Grant Notice and Option Agreement. The option shall become exercisable on the 12-month anniversary of the grant date, provided that the Reporting Person continues to provide services to the Issuer through such date."}],"balance_after":17500,"derivative":{"exercise_price":10,"expiration_date":"2035-03-28","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001213900-25-028778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026478/000121390025028778/ownership.xml","form_type":"4"}},{"id":1311224,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T21:17:04.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":25236,"price":3.17,"value":79998.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $80,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"6,309 shares underlying the option shall vest on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":25236,"derivative":{"exercise_price":4.38,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":25236},"source":{"system":"sec-edgar","filing":"0001999480-25-000004","document":"wk-form4_1736198217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000199948025000004/wk-form4_1736198217.xml","form_type":"4"}},{"id":1655513,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-02-07T21:39:18.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":281917,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Lightswitch Capital Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Lightswitch Capital Fund I, L.P. (\"Lightswitch Capital\"), of which Lightswitch Capital GP, LLC (\"Lightswitch GP\") is the sole general partner and exercises voting and investment power over these shares. The Reporting Person is the Chief Executive Officer of Lightswitch GP and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":126755},"source":{"system":"sec-edgar","filing":"0001415889-24-002938","document":"form4-02072024_090202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000141588924002938/form4-02072024_090202.xml","form_type":"4"}},{"id":1655512,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-02-07T21:39:18.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Lightswitch Capital Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Lightswitch Capital Fund I, L.P. (\"Lightswitch Capital\"), of which Lightswitch Capital GP, LLC (\"Lightswitch GP\") is the sole general partner and exercises voting and investment power over these shares. The Reporting Person is the Chief Executive Officer of Lightswitch GP and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":588898},"source":{"system":"sec-edgar","filing":"0001415889-24-002938","document":"form4-02072024_090202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000141588924002938/form4-02072024_090202.xml","form_type":"4"}},{"id":1655511,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:39:18.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":126755,"ownership":{"direct":false,"nature":"By Lightswitch Capital Fund I, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Lightswitch Capital Fund I, L.P. (\"Lightswitch Capital\"), of which Lightswitch Capital GP, LLC (\"Lightswitch GP\") is the sole general partner and exercises voting and investment power over these shares. The Reporting Person is the Chief Executive Officer of Lightswitch GP and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":715653,"source":{"system":"sec-edgar","filing":"0001415889-24-002938","document":"form4-02072024_090202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000141588924002938/form4-02072024_090202.xml","form_type":"4"}},{"id":1655510,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:39:18.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":588898,"ownership":{"direct":false,"nature":"By Lightswitch Capital Fund I, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Lightswitch Capital Fund I, L.P. (\"Lightswitch Capital\"), of which Lightswitch Capital GP, LLC (\"Lightswitch GP\") is the sole general partner and exercises voting and investment power over these shares. The Reporting Person is the Chief Executive Officer of Lightswitch GP and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":588898,"source":{"system":"sec-edgar","filing":"0001415889-24-002938","document":"form4-02072024_090202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000141588924002938/form4-02072024_090202.xml","form_type":"4"}},{"id":1659391,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T21:42:13.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":4623,"price":11.884,"value":54939.732,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $55,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"840 shares underlying the option shall vest on March 31, 2024, and 1,261 shares underlying the option shall vest on each of June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":4623,"derivative":{"exercise_price":16,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":4623},"source":{"system":"sec-edgar","filing":"0001415889-24-002558","document":"form4-02052024_090258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000141588924002558/form4-02052024_090258.xml","form_type":"4"}},{"id":1659390,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":45308,"kind":"person","name":"Cox Christopher Nixon","position":1,"cik":"0002008212","reported_name":"Cox Christopher Nixon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T21:42:13.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":30574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest in 36 equal monthly installments commencing on March 1, 2024, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":30574,"derivative":{"exercise_price":16,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":30574},"source":{"system":"sec-edgar","filing":"0001415889-24-002558","document":"form4-02052024_090258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008212/000141588924002558/form4-02052024_090258.xml","form_type":"4"}}]}